London : The UK on Monday began rolling out the Oxford/AstraZeneca vaccine against COVID-19, becoming the first nation to inoculate people with the cheaper and easy-to-handle jab outside of trials. The Oxford vaccine, which also has a tie-up with the Serum Institute of India, was first administered to Brian Pinker, an 82-year-old Oxford-born dialysis patient. Pinker is […]
Read MoreHyderabad : Amid questions raised by industry experts and opposition parties on the emergency approval to its coronavirus vaccine Covaxin without publication of efficacy data, Bharat Biotech’s chairman on Monday hit out at critics saying his firm had carried out ”200 per cent honest clinical trials”. Speaking to reporters at a virtual press conference, Krishna Ella said his firm has a […]
Read MoreMumbai: Rising for the ninth straight session, the BSE Sensex closed above the 48,000-mark for the first time on Monday as investor sentiment got a boost after India approved two coronavirus vaccines over the weekend. A strengthening rupee, positive global cues and encouraging macroeconomic data gave further impetus to risk appetite, traders said. The 30-share BSE Sensex ended 307.82 […]
Read MoreNew Delhi: Work is underway in full swing to set up centres for COVID-19 vaccination in the national capital with 500 such units to come up in the first phase, even as the storage facility is getting equipped with freezers to hold vaccines in a temperature range of 2-8 degrees Celsius. Delhi Health Minister Satyendar Jain on Sunday had […]
Read MoreNew Delhi: With some Congress leaders raising concerns over the grant of approval to Bharat Biotech‘s COVID-19 vaccine, Health Minister Harsh Vardhan asserted on Sunday that Covaxin is more likely to work against newer variants of the virus, including the UK variant, and asked politicians not to ”discredit well laid out science-backed protocols” followed for approving the jab. Some Congress leaders, […]
Read More